Literature DB >> 34422124

Global Advancement of Nuclear Medicine: KSNM 60 Years of Achievements.

Andrew M Scott1,2,3,4.   

Abstract

Entities:  

Year:  2021        PMID: 34422124      PMCID: PMC8322357          DOI: 10.1007/s13139-021-00700-y

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


× No keyword cloud information.
  6 in total

1.  Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project.

Authors:  Cathy S Cutler; Elizabeth Bailey; Vijay Kumar; Sally W Schwarz; Hee-Seung Bom; Jun Hatazawa; Diana Paez; Pilar Orellana; Lizette Louw; Fernando Mut; Hiroki Kato; Arturo Chiti; Savvas Frangos; Frederic Fahey; Gary Dillehay; Seung J Oh; Dong S Lee; Sze-Ting Lee; Rodolfo Nunez-Miller; Guru Bandhopadhyaya; Prasanta K Pradhan; Andrew M Scott
Journal:  J Nucl Med       Date:  2020-07-09       Impact factor: 10.057

2.  [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.

Authors:  Michael S Hofman; Louise Emmett; Shahneen Sandhu; Amir Iravani; Anthony M Joshua; Jeffrey C Goh; David A Pattison; Thean Hsiang Tan; Ian D Kirkwood; Siobhan Ng; Roslyn J Francis; Craig Gedye; Natalie K Rutherford; Andrew Weickhardt; Andrew M Scott; Sze-Ting Lee; Edmond M Kwan; Arun A Azad; Shakher Ramdave; Andrew D Redfern; William Macdonald; Alex Guminski; Edward Hsiao; Wei Chua; Peter Lin; Alison Y Zhang; Margaret M McJannett; Martin R Stockler; John A Violet; Scott G Williams; Andrew J Martin; Ian D Davis
Journal:  Lancet       Date:  2021-02-11       Impact factor: 79.321

3.  Short Essay on 60 Years' Challenges and Achievements of KSNM.

Authors:  Hyun Gee Ryoo; Minseok Suh; Jin Chul Paeng; June-Key Chung
Journal:  Nucl Med Mol Imaging       Date:  2021-02-01

4.  The Australasian Radiopharmaceutical Trials Network: Clinical Trials, Evidence, and Opportunity.

Authors:  Roslyn J Francis; Dale L Bailey; Michael S Hofman; Andrew M Scott
Journal:  J Nucl Med       Date:  2020-12-31       Impact factor: 10.057

Review 5.  Medical imaging and nuclear medicine: a Lancet Oncology Commission.

Authors:  Hedvig Hricak; May Abdel-Wahab; Rifat Atun; Miriam Mikhail Lette; Diana Paez; James A Brink; Lluís Donoso-Bach; Guy Frija; Monika Hierath; Ola Holmberg; Pek-Lan Khong; Jason S Lewis; Geraldine McGinty; Wim J G Oyen; Lawrence N Shulman; Zachary J Ward; Andrew M Scott
Journal:  Lancet Oncol       Date:  2021-03-04       Impact factor: 41.316

6.  Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.

Authors:  Michael S Hofman; Nathan Lawrentschuk; Roslyn J Francis; Colin Tang; Ian Vela; Paul Thomas; Natalie Rutherford; Jarad M Martin; Mark Frydenberg; Ramdave Shakher; Lih-Ming Wong; Kim Taubman; Sze Ting Lee; Edward Hsiao; Paul Roach; Michelle Nottage; Ian Kirkwood; Dickon Hayne; Emma Link; Petra Marusic; Anetta Matera; Alan Herschtal; Amir Iravani; Rodney J Hicks; Scott Williams; Declan G Murphy
Journal:  Lancet       Date:  2020-03-22       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.